From: Implementation mapping to plan for the Supraglottic Airway for Resuscitation (SUGAR) trial
CFIR Construct | Barrier/Facilitator Description |
---|---|
Innovation Domain | |
Innovation relative advantage | aMixed perceptions regarding the advantages and disadvantages of SA compared to alternatives |
Innovation evidence base | aMany providers unaware of evidence base for SA |
Innovation cost | Some perceptions that cost of SA is prohibitive |
Inner Setting | |
Access to knowledge and information | aMany providers have insufficient education and training in SA use |
Tension for change | aGeneral perception that ETT is the “go-to” practice when possible; lack of identified need for alternatives |
Materials and equipment | aAvailability or lack of availability of LMA supplies at hand in the moment they would be used (including correct size, accessibility, knowing where to find them) |
Compatibility | aHospital policies/workflows/norms that are incompatible with LMA use |
Culture – recipient-centeredness | Shared values, beliefs, and norms among units/teams about the importance of using evidence-based practices |
Outer Setting | |
Policies and laws | aPolicies related to scope of practice for particular providers; liability concerns |
Local attitudes | Shared professional attitudes about following evidence base and doing what is best for recipients |